Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. The Company's clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company's platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NYSE:RNA
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $19.00
- 200 Day Moving Avg: $14.00
- 52 Week Range: $4.00 - $23.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -19.00
- P/E Growth: 0
- Average Volume: 187,002 shs.
Frequently Asked Questions for Prosensa Holding NV (NYSE:RNA)
What is Prosensa Holding NV's stock symbol?
Prosensa Holding NV trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNA."
How were Prosensa Holding NV's earnings last quarter?
Prosensa Holding NV (NYSE:RNA) announced its earnings results on Monday, November, 17th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.04. View Prosensa Holding NV's Earnings History.
Who are some of Prosensa Holding NV's key competitors?
Some companies that are related to Prosensa Holding NV include HDFC Bank Limited (HDB), Berkshire Hathaway (BRK.B), Berkshire Hathaway (BRK.A), Exxon Mobil (XOM), Johnson & Johnson (JNJ), Alibaba Group Holding Ltd (BABA), JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC), Bank of America Corp (BAC), General Electric Company (GE), Wal-Mart Stores (WMT), Royal Dutch Shell plc (RDS.B), AT&T (T), Anheuser Busch Inbev NV (BUD), China Mobile (CHL), Procter & Gamble Co (PG), Royal Dutch Shell plc (RDS.A) and Visa (V).
How do I buy Prosensa Holding NV stock?
Shares of Prosensa Holding NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Prosensa Holding NV stock cost?
One share of Prosensa Holding NV stock can currently be purchased for approximately $19.00.
Consensus Ratings for Prosensa Holding NV (NYSE:RNA) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Prosensa Holding NV (NYSE:RNA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Prosensa Holding NV (NYSE:RNA)Earnings History by Quarter for Prosensa Holding NV (NYSE:RNA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/20/2014||Q114||$0.01||$0.26||$18.38 million||$20.23 million||View||N/A|
|3/17/2014||($0.14)||($0.12)||$2.92 million||$3.03 million||View||N/A|
Earnings Estimates for Prosensa Holding NV (NYSE:RNA)
Current Year EPS Consensus Estimate: $-1 EPS
Next Year EPS Consensus Estimate: $-1 EPS
Dividend History for Prosensa Holding NV (NYSE:RNA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Prosensa Holding NV (NYSE:RNA)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Prosensa Holding NV (NYSE:RNA)
Latest Headlines for Prosensa Holding NV (NYSE:RNA)
Prosensa Holding NV (RNA) Chart for Thursday, May, 25, 2017